Relaxin does not influence the growth of human cervical adenocarcinoma (HeLa) cells in culture
- Authors
- Rho, Y.S.; Min, G.
- Issue Date
- 2005
- Publisher
- New York Academy of Sciences
- Keywords
- Cervical adenocarcinoma; Estrogen; Growth; Nitric oxide; Progesterone; Relaxin
- Citation
- Annals of the New York Academy of Sciences, v.1041, pp 470 - 480
- Pages
- 11
- Indexed
- SCOPUS
- Journal Title
- Annals of the New York Academy of Sciences
- Volume
- 1041
- Start Page
- 470
- End Page
- 480
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/29205
- DOI
- 10.1196/annals.1282.071
- ISSN
- 0077-8923
1749-6632
- Abstract
- This study was performed to determine whether relaxin influences the growth of human adenocarcinoma (HeLa) cells of the cervix, which has been shown to contain relaxin-binding sites and proliferate by relaxin. Cells were maintained in Dulbecco's modified Eagle's medium with 5% fetal calf serum. Highly purified porcine relaxin was added at concentrations of 10-11 to 10 -5 M and incubated for 44, 69, 94, and 118 h. Cell proliferation/cytotoxicity and endogenous nitric oxide production were determined using a colorimetric MTS assay and Griess assay, respectively. The results indicate that whereas relaxin promotes the growth rate of MCF-7 cells, which is in agreement with previous reports, at the doses and times of exposure used in this study relaxin does not significantly influence the number of viable HeLa cells. However, relaxin at nanomolar concentrations (10-9 to 10-8 M) promoted the growth of HeLa cells in the presence of both estrogen and progesterone to a small extent. In agreement with these results, relaxin did not affect nitric oxide production. We conclude that relaxin may have differential effects on the growth of two different cancer cell types, MCF-7 and HeLa cells. ? 2005 New York Academy of Sciences.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 간호대학 > Department of Nursing > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.